During the past decade, Hospital Universitario Virgen de la Victoria conducted 331 clinical trials. In the 10-year time frame, 331 clinical trials started and 101 clinical trials were completed, i.e. on average, 30.5% percent of trials that started reached the finish line to date. In the past 5 years, 164 clinical trials started and 66 clinical trials were completed. i.e. 40.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Virgen de la Victoria" #1 sponsor was "PETHEMA Foundation" with 30 trials, followed by "Janssen Research & Development, LLC" with 19 trials sponsored, "Celgene" with 18 trials sponsored, "Boehringer Ingelheim" with 16 trials sponsored and "Spanish Breast Cancer Research Group" with 16 trials sponsored. Other sponsors include 359 different institutions and companies that sponsored additional 190 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Virgen de la Victoria" #1 collaborator was "Pfizer" with 11 trials as a collaborator, "Eli Lilly and Company" with 9 trials as a collaborator, "AstraZeneca" with 7 trials as a collaborator, "Hoffmann-La Roche" with 7 trials as a collaborator and "Bristol-Myers Squibb" with 6 trials as a collaborator. Other collaborators include 258 different institutions and companies that were collaborators in the rest 202 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Virgen de la Victoria" are "Breast Cancer" (26 trials), "Heart Failure" (20 trials), "Atrial Fibrillation" (11 trials), "Acute Lymphoblastic Leukemia" (8 trials) and "HIV Infections" (8 trials). Many other conditions were trialed in "Hospital Universitario Virgen de la Victoria" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Virgen de la Victoria" are "Drug" (334 trials), "Other" (42 trials), "Device" (36 trials), "Biological" (31 trials) and "Procedure" (25 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (62 trials), "Prednisone" (18 trials), "Cyclophosphamide" (14 trials), "Carboplatin" (13 trials) and "Dexamethasone" (12 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Virgen de la Victoria" are 397 trials for "All" genders, 32 trials for "Female" genders and 32 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Virgen de la Victoria". 2 are not yet recruiting, 113 are recruiting, 69 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 204 completed trials in Hospital Universitario Virgen de la Victoria, 1 suspended trials, and 36 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Virgen de la Victoria, 59 "Phase 1" clinical trials were conducted, 119 "Phase 2" clinical trials and 158 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 40 trials, and there were also 27 trials that are defined as “Not Applicable".

Hospital Universitario Virgen de la Victoria has several departments that took part in Clinical trials: "Hospital Clinico Universitario Virgen de la Victoria; Servicio de Oncologia" - 32 trials, "Hospital Clinico Universitario Virgen de la Victoria; Servicio de Hematologia" - 3 trials